ANTI-KLRG1 ANTIBODIES
The disclosure relates to antibodies, or antigen-binding fragments thereof, that specifically bind to killer cell lectin-like receptor G1 (KLRG1). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes, including treatment of cancers and to i...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
22.02.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The disclosure relates to antibodies, or antigen-binding fragments thereof, that specifically bind to killer cell lectin-like receptor G1 (KLRG1). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes, including treatment of cancers and to increase the effectiveness of vaccines. |
|---|---|
| AbstractList | The disclosure relates to antibodies, or antigen-binding fragments thereof, that specifically bind to killer cell lectin-like receptor G1 (KLRG1). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes, including treatment of cancers and to increase the effectiveness of vaccines. |
| Author | GULLA, Stefano THOMPSON, Kenneth |
| Author_xml | – fullname: GULLA, Stefano – fullname: THOMPSON, Kenneth |
| BookMark | eNrjYmDJy89L5WQQdfQL8dT19glyN1QAMZ38XTxdg3kYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbxjqJGBkZGRiZmhmYmjpTFxqgDOmSFQ |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | AU2022246164A9 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_AU2022246164A93 |
| IEDL.DBID | EVB |
| IngestDate | Fri Sep 20 10:12:44 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_AU2022246164A93 |
| Notes | Application Number: AU20220246164 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240222&DB=EPODOC&CC=AU&NR=2022246164A9 |
| ParticipantIDs | epo_espacenet_AU2022246164A9 |
| PublicationCentury | 2000 |
| PublicationDate | 20240222 |
| PublicationDateYYYYMMDD | 2024-02-22 |
| PublicationDate_xml | – month: 02 year: 2024 text: 20240222 day: 22 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | THE BRIGHAM AND WOMEN'S HOSPITAL, INC |
| RelatedCompanies_xml | – name: THE BRIGHAM AND WOMEN'S HOSPITAL, INC |
| Score | 3.5312674 |
| Snippet | The disclosure relates to antibodies, or antigen-binding fragments thereof, that specifically bind to killer cell lectin-like receptor G1 (KLRG1). Such... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| Title | ANTI-KLRG1 ANTIBODIES |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240222&DB=EPODOC&locale=&CC=AU&NR=2022246164A9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTI3TjI0NE7UTTGxtNA1STFK0rUwSUnUNUpLA_YOEkE7EkAdRV8_M49QE68I0wgmhhzYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dg6YKjIzUXJxsXQP8Xfyd1ZydgT1JNb8gkBz46DQzE0dLZgZWUEMadNK-a5gTaF9KAXKl4ibIwBYANC-vRIiBKTVPmIHTGXb3mjADhy90yhvIhOa-YhEGUUe_EE9db58gd0MFENPJH9SYE2VQdnMNcfbQBZofD_dOvGMosmOMxRhYgB39VAkGBfPUFGOLFGCDDJSVUg0NE4HNMYukRLNkU2BNlphiJMkgg88kKfzS0gxcoAACb8c2kmFgKSkqTZUFVqglSXLgcAAABcl1OQ |
| link.rule.ids | 230,309,786,891,25594,76904 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTI3TjI0NE7UTTGxtNA1STFK0rUwSUnUNUpLA_YOEkE7EkAdRV8_M49QE68I0wgmhhzYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dg6YKjIzUXJxsXQP8Xfyd1ZydgT1JNb8gkBz46DQzE0dLZgZWc2CnEHTSvmuYE2hfSgFypeImyMAWADQvr0SIgSk1T5iB0xl295owA4cvdMobyITmvmIRBlFHvxBPXW-fIHdDBRDTyR_UmBNlUHZzDXH20AWaHw_3TrxjKLJjjMUYWIAd_VQJBgXz1BRjixRggwyUlVINDROBzTGLpESzZFNgTZaYYiTJIIPPJCn80vIMnB4hvj7xPp5-3tIMXKDAAm_NNpJhYCkpKk2VBVauJUly4DABAKbPeCQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-KLRG1+ANTIBODIES&rft.inventor=GULLA%2C+Stefano&rft.inventor=THOMPSON%2C+Kenneth&rft.date=2024-02-22&rft.externalDBID=A9&rft.externalDocID=AU2022246164A9 |